BDX
Becton, Dickinson and CompanyNYSEHealthcare$154.51-1.17%OpenMarket Cap: $55.98B
As of 2026-04-06
Valuation
P/E (TTM)
31.86
PEG
18.34
P/B
1.74
P/S
2.55
EV/EBITDA
14.62
DCF Value
$1,365.05
FCF Yield
4.7%
Div Yield
2.3%
Margins & Returns
Gross Margin
45.8%
Operating Margin
12.4%
Net Margin
8.0%
ROE
6.9%
ROA
9.2%
ROIC
4.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $5.25B | 44.6% | $594.0M | $382.0M | $1.34 | $1.05 |
| Q4 2025 | $5.89B | 47.5% | $697.0M | $493.0M | $1.72 | $1.04 |
| FY 2025 | $21.84B | 45.4% | $2.58B | $1.68B | $5.83 | $4.16 |
| Q3 2025 | $5.51B | 47.8% | $882.0M | $574.0M | $2.00 | $1.04 |
| Q2 2025 | $5.27B | 42.8% | $546.0M | $308.0M | $1.07 | $1.04 |
| Q1 2025 | $5.17B | 43.2% | $453.0M | $303.0M | $1.04 | $1.04 |
| Q4 2024 | $5.44B | 45.7% | $622.0M | $400.0M | $1.45 | $0.95 |
| FY 2024 | $20.18B | 45.2% | $2.40B | $1.71B | $5.86 | $3.80 |
| Q3 2024 | $4.99B | 46.2% | $602.0M | $487.0M | $1.68 | $0.95 |
| Q2 2024 | $5.04B | 45.7% | $734.0M | $537.0M | $1.85 | $0.95 |
| Q1 2024 | $4.71B | 43.1% | $439.0M | $281.0M | $0.96 | $0.95 |
| Q4 2023 | $5.09B | 33.4% | $349.0M | $108.0M | $0.37 | $0.91 |